376.4 ð ç« æ«éèš Summary
376.4.1 ð äžå¥è©±çžœçµ
Delirium (acute confusional state) = DSM-5: (1) disturbance in attention + awareness + (2) develops short period (hours-days) + fluctuates + (3) cognitive disturbance + (4) not better explained by other NCD + (5) evidence of physiological cause (medical/drug/withdrawal/multifactorial); hallmark = inattention; subtypes â hyperactive 25% (agitation, easier to recognize) + hypoactive 50% (lethargic withdrawn â OFTEN MISSED, WORST PROGNOSIS) + mixed 25%; epidemiology â ~ 20% hospitalized older adults + 50-80% ICU patients + 30% post-surgical elderly + 70% post-hip fracture + 90% terminal illness; predisposing factors â age > 65 + pre-existing dementia (most important) + prior delirium + multi-comorbidity + severe illness + functional impairment + sensory impairment (visual, hearing) + depression + substance use + frailty; precipitating factors â medications #1 cause (anticholinergics oxybutynin/scopolamine/diphenhydramine/TCAs + benzodiazepines + opioids especially meperidine accumulates normeperidine + sedatives + steroids + antiparkinsonian) + infection (UTI elderly, pneumonia, sepsis, COVID-19) + metabolic (hypoglycemia, hyperglycemia, hyponatremia, hypercalcemia, uremia, hepatic) + withdrawal (alcohol DTs, BZD, opioid) + hypoxia/hypercapnia + stroke/TBI/SDH/seizure + surgery (post-op, hip fracture, cardiac surgery) + ICU factors (sleep deprivation, sensory overload/deprivation, immobilization, restraints, multiple medications) + pain undertreated + urinary retention + constipation + dehydration + malnutrition; assessment â CAM (Confusion Assessment Method): (1) acute onset + fluctuating + (2) inattention + (either) (3) disorganized thinking OR (4) altered LOC; CAM-ICU for ICU/intubated; baseline collateral history critical; labs (electrolytes, glucose, Ca, Mg, LFTs, ammonia, TFTs, B12, UA + culture, CXR, ECG, drug levels, toxicology, blood cultures if febrile); selective imaging (CT head for focal deficit/trauma/stroke), LP (meningitis suspected), EEG (NCSE suspected); delirium vs dementia distinction â delirium acute + fluctuating + inattention hallmark + altered LOC + often reversible; dementia insidious + progressive + memory hallmark + clear LOC + usually not reversible; delirium superimposed on dementia common in high-risk hospitalized older adults; management â non-pharmacologic FIRST-LINE â HELP program (Hospital Elder Life Program, Inouye 1999 NEJM, reduces incidence ~ 40%): reorientation (clocks, calendars) + sleep enhancement (non-pharm) + mobilization + visual + hearing aids + hydration + family involvement + avoid restraints; environmental quiet/well-lit day + dark night + familiar objects; medical optimization identify + treat underlying cause(s) + discontinue/minimize culprit drugs + treat infection + correct electrolytes + manage pain (acetaminophen first, minimize opioids, AVOID meperidine in elderly) + bowel/bladder regularity + adequate hydration/nutrition + sleep hygiene + melatonin; pharmacologic LAST RESORT for severe agitation/danger to self+others/distress/interfering with medical care â low-dose haloperidol 0.5-1 mg PO/IM/IV or atypical antipsychotics (quetiapine 12.5-50 mg preferred for PD/DLB, risperidone 0.25-1 mg, olanzapine 2.5-5 mg) â AVOID benzodiazepines (paradoxical worsening â EXCEPT for alcohol/BZD withdrawal) + AVOID anticholinergics; QT prolongation check + EPS/NMS/parkinsonism + mortality BBW dementia + lowest dose shortest duration; dexmedetomidine (α2 agonist) ICU sedation alternative to propofol/BZDs â less delirium (MIDEX, PRODEX, SEDCOM, MENDS, DESIRE); alcohol withdrawal delirium (DTs) 48-96 hr after last drink â BZDs first-line (lorazepam, diazepam) + thiamine before glucose + magnesium + phenobarbital alternative + ICU for severe + mortality 5-15% untreated; ICU delirium â minimize BZDs + dexmedetomidine + ABCDEF bundle + daily SAT/SBT + early mobilization; MIND-USA 2018: antipsychotics did NOT change delirium duration/outcome â reinforces non-pharm primary; consequences â prolonged hospital stay 5-10 days + â mortality 2-3x at 1 year + â institutionalization + accelerated cognitive decline + accelerated dementia trajectory + â healthcare costs + may persist months; prevention â multicomponent non-pharm HELP + geriatric consultation + avoid high-risk meds + pre-op optimization + early mobilization + sleep promotion + adequate analgesia non-opioid firstã
376.4.2 ð æ²»ç粟èŠ
- non-pharmacologic FIRST-LINE (HELP program)ïŒreorientation (clocks, calendars, communication) + sleep enhancement non-pharm (dim lights, quiet, no daytime naps) + early mobilization + glasses + hearing aids + hydration + nutrition + family involvement + avoid restraints + minimize tethers (catheters, IVs, monitors)
- medical optimizationïŒidentify + treat underlying cause(s) (infection, electrolytes, withdrawal, drugs); discontinue/minimize culprit drugs (anticholinergics, BZDs, opioids minimize meperidine NEVER); acetaminophen first for pain; bowel + bladder regularity (laxatives, bladder scan); adequate hydration/nutrition
- pharmacologic LAST RESORT for severe agitationïŒhaloperidol 0.5-1 mg PO/IM/IV q4-6h (low dose elderly, ECG for QT, watch EPS); atypical antipsychotics â quetiapine 12.5-50 mg HS preferred for PD/DLB + risperidone 0.25-1 mg + olanzapine 2.5-5 mg; AVOID benzodiazepines (paradoxical worsening â EXCEPT alcohol/BZD withdrawal) + AVOID anticholinergics + AVOID meperidine in elderly
- ICU sedationïŒdexmedetomidine 0.2-1.4 ÎŒg/kg/h (less delirium vs propofol/BZDs); minimize BZDs; daily SAT (spontaneous awakening trial) + SBT (spontaneous breathing trial); early mobilization; ABCDEF bundle
- alcohol withdrawal delirium (DTs)ïŒlorazepam 2-4 mg IV q15-30 min PRN OR diazepam 5-10 mg IV q5-10 min PRN (titrated to symptom-triggered CIWA-Ar) + thiamine 500 mg IV TID à 3 days BEFORE glucose + magnesium + glucose + multivitamin + phenobarbital alternative + ICU for severe (mortality 5-15% untreated)
- catatonia (delirium mimic)ïŒlorazepam challenge 1-2 mg IV often diagnostic + therapeutic; ECT for refractory
- prevention (HELP program reduces incidence ~ 40%)ïŒmulticomponent non-pharm + geriatric consultation + avoid high-risk meds (Beers criteria, anticholinergic burden) + pre-op optimization + early mobilization + sleep promotion + adequate analgesia + melatonin 3-5 mg HS may help
376.4.3 ð¯ ç§é«åž«çèåæé
- Delirium DSM-5 criteria (memorize): (1) disturbance in attention + awareness + (2) develops hours-days + fluctuates + (3) cognitive disturbance + (4) not better explained + (5) physiological cause â hallmark INATTENTION (most characteristic feature)
- Subtypes: hyperactive 25% (agitation, easier to recognize) + hypoactive 50% (lethargic withdrawn â OFTEN MISSED + WORST PROGNOSIS) + mixed 25%; screen all admitted older adults with CAM
- CAM (Confusion Assessment Method): (1) acute onset + fluctuating + (2) inattention + (either) (3) disorganized thinking OR (4) altered LOC; CAM-ICU for intubated/ICU patients
- Common precipitants (mnemonic ABCDEFG-H): A anticholinergics (oxybutynin, scopolamine, diphenhydramine, TCAs) + B benzodiazepines + C cardiovascular (digoxin, diuretics, β-blockers) + D drugs/dehydration + E ENT (antihistamines) + F furosemide (electrolytes) + G GI (H2 blockers, antiemetics) + H hormones (steroids)
- Delirium vs dementia distinction: delirium (acute + fluctuating + inattention hallmark + altered LOC + often reversible) vs dementia (insidious + progressive + memory hallmark + clear LOC early + usually not reversible); delirium superimposed on dementia common in hospitalized older adults
- Management â non-pharmacologic FIRST-LINE (HELP program reduces ~ 40%): reorientation + sleep enhancement + mobilization + sensory aids + hydration + family + avoid restraints + minimize tethers
- Medical optimization: identify + treat underlying cause(s) + discontinue/minimize culprit drugs + treat infection + correct electrolytes + manage pain (acetaminophen first) + bowel/bladder regularity
- Pharmacologic LAST RESORT for severe agitation: low-dose haloperidol 0.5-1 mg or atypical antipsychotics (quetiapine 12.5-50 mg preferred for PD/DLB) â AVOID benzodiazepines (paradoxical) EXCEPT for alcohol/BZD withdrawal; AVOID meperidine + anticholinergics in elderly
- ICU delirium specific: dexmedetomidine over BZDs (less delirium â MIDEX, PRODEX, SEDCOM, MENDS, DESIRE) + ABCDEF bundle + daily SAT/SBT + early mobilization; MIND-USA 2018: antipsychotics did NOT change duration/outcome â reinforces non-pharm primary
- Alcohol withdrawal delirium (DTs) 48-96 hr after last drink: severe autonomic + hallucinations + seizures possible + mortality 5-15% untreated â BZDs first-line (lorazepam, diazepam) symptom-triggered CIWA-Ar + thiamine 500 mg IV TID BEFORE glucose (Wernicke prevention) + magnesium + ICU for severe; delirium â â mortality 2-3x at 1 year + accelerated cognitive decline â prevention is key